» Articles » PMID: 36612300

Protoporphyrin IX (PpIX) Fluorescence During Meningioma Surgery: Correlations with Histological Findings and Expression of Heme Pathway Molecules

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jan 8
PMID 36612300
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The usefulness of 5-ALA-mediated fluorescence-guided resection (FGR) in meningiomas is controversial, and information on the molecular background of fluorescence is sparse. Methods: Specimens obtained during 44 FGRs of intracranial meningiomas were analyzed for the presence of tumor tissue and fluorescence. Protein/mRNA expression of key transmembrane transporters/enzymes involved in PpIX metabolism (ABCB6, ABCG2, FECH, CPOX) were investigated using immunohistochemistry/qPCR. Results: Intraoperative fluorescence was observed in 70 of 111 specimens (63%). No correlation was found between fluorescence and the WHO grade (p = 0.403). FGR enabled the identification of neoplastic tissue (sensitivity 84%, specificity 67%, positive and negative predictive value of 86% and 63%, respectively, AUC: 0.75, p < 0.001), and was improved in subgroup analyses excluding dura specimens (86%, 88%, 96%, 63% and 0.87, respectively; p < 0.001). No correlation was found between cortical fluorescence and tumor invasion (p = 0.351). Protein expression of ABCB6, ABCG2, FECH and CPOX was found in meningioma tissue and was correlated with fluorescence (p < 0.05, each), whereas this was not confirmed for mRNA expression. Aberrant expression was observed in the CNS. Conclusion: FGR enables the intraoperative identification of meningioma tissue with limitations concerning dura invasion and due to ectopic expression in the CNS. ABCB6, ABCG2, FECH and CPOX are expressed in meningioma tissue and are related to fluorescence.

Citing Articles

Fluorescence and immune-cell infiltration of nonneoplastic, postbrachytherapy brain tissue in 5-ALA-guided resection of recurrent anaplastic meningioma: illustrative case.

Ramapriyan R, Clark V, Martinez-Lage M, Hsueh B, Nahed B, Curry W J Neurosurg Case Lessons. 2024; 7(9).

PMID: 38408351 PMC: 10901117. DOI: 10.3171/CASE23550.


Intraoperative Imaging and Optical Visualization Techniques for Brain Tumor Resection: A Narrative Review.

Bin-Alamer O, Abou-Al-Shaar H, Gersey Z, Huq S, Kallos J, McCarthy D Cancers (Basel). 2023; 15(19).

PMID: 37835584 PMC: 10571802. DOI: 10.3390/cancers15194890.

References
1.
Goldbrunner R, Stavrinou P, Jenkinson M, Sahm F, Mawrin C, Weber D . EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021; 23(11):1821-1834. PMC: 8563316. DOI: 10.1093/neuonc/noab150. View

2.
Simpson D . The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957; 20(1):22-39. PMC: 497230. DOI: 10.1136/jnnp.20.1.22. View

3.
Traylor J, Pernik M, Sternisha A, McBrayer S, Abdullah K . Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas. Cancers (Basel). 2021; 13(3). PMC: 7867275. DOI: 10.3390/cancers13030580. View

4.
Pustogarov N, Panteleev D, Goryaynov S, Ryabova A, Rybalkina E, Revishchin A . Hiding in the Shadows: CPOX Expression and 5-ALA Induced Fluorescence in Human Glioma Cells. Mol Neurobiol. 2016; 54(7):5699-5708. DOI: 10.1007/s12035-016-0109-7. View

5.
Nordmann N, Michael A . 5-Aminolevulinic acid radiodynamic therapy for treatment of high-grade gliomas: A systematic review. Clin Neurol Neurosurg. 2020; 201:106430. DOI: 10.1016/j.clineuro.2020.106430. View